Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81−0.00 (-0.17%)
Close on Nov 12, 2026Market cap $9.43MP/E –Yield –
Phio Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Phio Pharmaceuticals's ebitda for the twelve months ending Sep 30, 2026 was -$15.23M. For fiscal 2025 it was -$9.22M. The highest annual figure on record is -$7.28M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.22M | – |
| FY2024 | Dec 31, 2024 | -$7.39M | – |
| FY2023 | Dec 31, 2023 | -$10.77M | – |
| FY2022 | Dec 31, 2022 | -$11.39M | – |
| FY2021 | Dec 31, 2021 | -$13.44M | – |
| FY2020 | Dec 31, 2020 | -$8.72M | – |
| FY2019 | Dec 31, 2019 | -$8.92M | – |
| FY2018 | Dec 31, 2018 | -$7.28M | – |
| FY2017 | Dec 31, 2017 | -$13.99M | – |
| FY2016 | Dec 31, 2016 | -$8.96M | – |
| FY2015 | Dec 31, 2015 | -$10.16M | – |
| FY2014 | Dec 31, 2014 | -$8.74M | – |
| FY2013 | Dec 31, 2013 | -$20.85M | – |
| FY2012 | Dec 31, 2012 | -$12.83M | – |
| FY2011 | Dec 31, 2011 | -$12.61M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$4.27M | – |
| Q2 FY2026 | Jun 30, 2026 | -$4.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.50M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.87M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.89M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.76M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.53M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.72M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.56M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.50M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.43M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.72M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.45M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.29M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.65M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.34M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.65M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.10M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.13M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.71M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.47M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.88M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.22M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.97M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.46M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.07M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.33M | – |
See a number that looks wrong?